AZN earnings
AstraZeneca (AZN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
AZN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 30, 2026 | 2.79 | 2.60 | 7.31% | $15.99B |
| Q2 2026 | Jul 27, 2026 | 2.63 | 2.50 | 5.20% | $15.38B |
| Q1 2026 | Apr 29, 2026 | 2.58 | 2.57 | 0.39% | $15.29B |
| Q4 2025 | Feb 10, 2026 | 2.12 | 2.09 | 1.44% | $15.50B |
| Q3 2025 | Nov 6, 2025 | 2.38 | 2.28 | 4.39% | $15.19B |
| Q2 2025 | Jul 29, 2025 | 2.18 | 2.18 | 0.00% | $14.46B |
| Q1 2025 | Apr 29, 2025 | 2.48 | 2.20 | 12.73% | $13.59B |
| Q4 2024 | Feb 6, 2025 | 2.10 | 2.07 | 1.45% | $14.89B |
| Q3 2024 | Nov 11, 2024 | 2.08 | 2.02 | 2.97% | $13.56B |
| Q2 2024 | Jul 24, 2024 | 1.98 | 1.92 | 3.13% | $12.94B |
| Q1 2024 | Apr 25, 2024 | 2.06 | 1.90 | 8.42% | $12.68B |
| Q4 2023 | Feb 8, 2024 | 1.46 | 1.48 | -1.35% | $12.02B |
| Nov 9, 2023 | 0.86 | 0.84 | 2.61% | – | |
| Jul 28, 2023 | 1.08 | 0.99 | 9.31% | – | |
| Apr 27, 2023 | 1.16 | 1.07 | 8.41% | – | |
| Feb 9, 2023 | 0.69 | 0.67 | 2.68% | – | |
| Nov 10, 2022 | 0.84 | 0.76 | 10.82% | – | |
| Jul 29, 2022 | 0.86 | 0.78 | 9.83% | – | |
| Apr 29, 2022 | 1.90 | 0.86 | 120.93% | – | |
| Feb 10, 2022 | 1.68 | 0.77 | 118.18% | – |
- AZN reports next on Feb 9, 2027, with EPS of 2.50 expected.
- AZN beat EPS estimates in 97 of its last 109 reports.
Updated 2026-11-02 18:32 UTC